Allogene Therapeutics, Inc. · NASDAQ:ALLO
Frazier Life Sciences Public Fund, L.P. reported a 4.70% stake in Allogene Therapeutics, Inc. (Schedule 13G)
Event Apr 16, 2026 · Filed Apr 23, 2026
Frazier Life Sciences Public Fund, L.P. reported a 4.70% stake in Allogene Therapeutics, Inc., 16,205,306 shares, as a passive investor on Apr 16, 2026. Filed Apr 23, 2026 (Schedule 13G).
- Stake
- 4.70%
- Shares
- 16,205,306
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 14 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Frazier Life Sciences Public Fund, L.P. | 4.70% | 16,205,306 |
| FHMLSP, L.P. | 4.70% | 16,205,306 |
| FHMLSP, L.L.C. | 4.70% | 16,205,306 |
| Frazier Life Sciences X, L.P. | 0.10% | 306,906 |
| FHMLS X, L.P. | 0.10% | 306,906 |
| FHMLS X, L.L.C. | 0.10% | 306,906 |
| Frazier Life Sciences XI, L.P. | 0.20% | 722,956 |
| FHMLS XI, L.P. | 0.20% | 722,956 |
| FHMLS XI, L.L.C. | 0.20% | 722,956 |
| Frazier Life Sciences XII, L.P. | 0.50% | 1,561,500 |
| FHMLS XII, L.P. | 0.50% | 1,561,500 |
| FHMLS XII, L.L.C. | 0.50% | 1,561,500 |
| James N. Topper | 0.10% | 306,906 |
| Patrick J. Heron | 0.10% | 306,906 |
Source
Related
- Allogene Therapeutics, Inc.
- Frazier Life Sciences Public Fund, L.P.
- Allogene Therapeutics, Inc. shareholders
- Schedule 13G/A · Frazier Life Sciences Public Fund, L.P. · Aug 14, 2026
- Form 4 · Parker Geoffrey M. · Oct 23, 2026
- Schedule 13D/A · Tpg Gp A, LLC · Sep 30, 2026
- Form 4 · Douglas Earl Martin · Aug 25, 2026
- Schedule 13G/A · Arie Belldegrun, M.D. · Aug 7, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026